Cogent Biosciences (COGT) Financials

$33.19

$0.65 (2.00%)

As on 17-Sep-2026 16:00EDT

Market cap

$5,797 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

12.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	2.33	4.62	4.40	3.59	5.88	0.15
Gross Profit	-2.33	-4.62	-4.40	-3.59	-5.88	-0.15
Operating Expenses	386.76	328.74	275.94	208.13	147.84	75.55
Operating Profit (EBIT)	-389.09	-333.36	-275.94	-208.13	-147.84	-75.55
Other Income	--	--	--	--	7.60	3.28
Profit before Tax	-377.18	-328.94	-255.86	-192.41	-140.24	-72.27
Provision for Tax	--	--	--	--	-7.60	-0.47
Profit after Tax (Net Income)	-377.18	-328.94	-255.86	-192.41	-132.64	-72.27
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-140.24	-72.27

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	532.39	636.37	256.29	257.80	255.74	214.18
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	242.86	237.28	15.90	17.47	18.23	0.83
Current Liabilities	59.30	63.95	55.71	38.17	26.85	17.08
Total Liabilities	893.84	937.61	327.90	313.44	300.81	232.09

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	29.73	27.25	31.43	42.67	35.84	9.46
Current Assets	804.82	910.36	296.47	270.77	264.97	222.63
Total Assets	893.84	937.61	327.90	313.44	300.81	232.09
Total Debt*	244.26	253.15	17.47	18.85	19.65	3.16
Net Current Assets	745.52	846.40	240.76	232.60	238.12	205.56

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-264.44	-207.79	-153.62	-118.64	-58.76
Cash Flow from Investing Activities	--	-399.53	38.28	-97.82	-124.72	-1.72
Cash from Financing Activities	--	878.23	214.45	163.54	163.56	37.98
Net Cash Inflow / Outflow	--	--	--	--	-79.80	-22.51

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.35	-2.04	-2.32	-2.22	-1.88	-1.65
Cash EPS ($)	--	-2.01	-2.28	-2.18	-1.80	-1.65
Adjusted Book Value ($)	--	3.95	2.32	2.97	3.63	4.89
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.64	-1.88	-1.77	-1.68	-1.34
Free Cash Flow per Share ($)	--	-1.65	-1.89	-1.80	-1.78	-1.38

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-56.55	-92.97	-69.71	-53.84	-31.61
ROE (%)	-64.54	-73.70	-99.54	-74.94	-56.45	-32.20
ROA (%)	-61.48	-51.99	-79.79	-62.65	-49.78	-29.93
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-1,745.76	-2,204.79
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	-1.00
EBIT Growth (%)	-32.70	-27.37	-32.98	-30.15	-104.56	-104.80
Net Profit Growth (%)	-32.77	-28.56	-32.98	-45.06	-83.53	3.39
EPS Growth (%)	7.28	0.12	-0.04	-0.18	-0.14	0.77
Book Value Growth (%)	128.78	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-17.38	-3.37	-2.65	-6.14	-5.20
Price / Book Value	12.65	8.99	3.36	1.98	3.19	1.75
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.89	-15.78	-2.35	-1.39	-4.05	-2.27
Close Price ($)	38.70	35.52	7.80	5.88	11.56	8.58
High Price ($)	43.73	43.73	12.61	15.68	18.07	13.24
Low Price ($)	7.07	3.72	4.28	3.67	3.79	5.83
Market Cap ($ Cr)	5,797.47	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.42	0.40	0.07	0.07	0.08	0.01
Short term debt to equity ratio	0.00	0.00	0.01	0.01	0.01	0.01
Current Ratio	13.57	14.23	5.32	7.09	9.87	13.04
Quick Ratio	13.57	--	--	--	--	--
Interest Coverage	-71.84	-106.43	--	--	-37.06	-23.08

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	850.73	940.64	839.68	289.72	5,236.49
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.